Liquids, gels, powders and pastes are not merely four package labels. They represent manufacturing conditions that affect batching, transfer, metering, filling, packaging and line changeover. A change in viscosity, particle form, fragrance or concentration within the same category may require another equipment and process review.
The first step is still a clear product requirement. ISO’s supply-chain guidance says a quality-management system does not replace the purchaser’s duty to specify requirements, standards and expectations. Brand and manufacturer should align on target market, scenario, dosage form, package and evaluation method.
The second step translates formulation direction into producible fields, such as raw-material form, order of addition, temperature boundary, mixing conditions, resting state and batch variation. These are review fields, not a claim that every product uses the same process or contains particular ingredients.
The third step checks filling and packaging. Liquid flow, gel viscosity, powder dust and paste filling behaviour may require different equipment conditions. Bottle, pouch, pump, closure and seal also need review with the contents and transport scenario. A packaging sample does not prove mass production or market launch.
The fourth step manages documents and safety boundaries. OSHA’s SDS structure separates product identification, recommended and restricted uses, hazards and disposal. Documents should follow the project version; an old file should not be copied mechanically to a new formulation or market.
EPHYON’s public ODM page lists formulation, fragrance, dosage form, sampling, packaging and scale-up review; its OEM page places existing specifications, formulation and package fit into the production flow. The pages also state that the Fengrun base covers liquids and gels and the Nanpu base covers powders and pastes. This article cites those public capability nodes without promising capacity, MOQ or lead time for a project.
Product and package versions also need stable identification. GS1 uses the GTIN to identify trade items uniquely and it can serve as an external identification reference. Internal formulation, packaging, batch and change records still remain necessary; one trade-item number cannot replace all manufacturing documentation.
The output of dosage-form selection should therefore be more than “make a gel” or “make a powder”. It should include a requirement version, sample number, package plan, equipment fit, quality items and change record. A traceable fit-review process is the foundation for moving from an idea to stable manufacturing.